Sort
48,018 grants matching “immunotherapy”
Structure and Function of T Cell Antigen Receptors
$371,250Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2011 · AI
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
$371,250Guangjie Cheng · University Of Alabama At Birmingham · R01 · FY2020 · AI
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
$371,250Guangjie Cheng · University Of Alabama At Birmingham · R01 · FY2022 · AI
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
$371,250Guangjie Cheng · University Of Alabama At Birmingham · R01 · FY2019 · AI
Ligand Guided Selection of Aptamers against Human Leukemia and Lymphoma
$371,250Prabodhika Mallikaratchy · Herbert H. Lehman College · SC1 · FY2019 · GM
Structure and Function of T Cell Antigen Receptors
$371,250Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2012 · AI
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
$371,250Wendy T Watford · University Of Georgia · R01 · FY2017 · AI
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$371,226Katherine B Chiappinelli · George Washington University · R37 · FY2025 · CA
Immunization Strategies for Autologous HIV Immunotherapy
$371,213Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AI
Immune Response to Cat: Regulatory and Effector T Cells
$371,213Judith A Woodfolk · University Of Virginia · R01 · FY2011 · AI
Immunization Strategies for Autologous HIV Immunotherapy
$371,213Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AI
Developmental Funds
$371,170Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
Role of Myeloid And CD4+ T Immune Cells in Post-Traumatic Plasticity
$371,162Jeanne T Paz · J. David Gladstone Institutes · R01 · FY2025 · NS
Structural Immunology of Classical and Non-classical MHC
$371,160Ian A Wilson · Scripps Research Institute, The · R01 · FY2006 · CA
Ceramide metabolism and the regulation of PD-L1 signaling to control metastasis and resistance to immunotherapy in TNBC
$371,074Besim Ogretmen · Medical University Of South Carolina · R01 · FY2023 · CA
Ceramide metabolism and the regulation of PD-L1 signaling to control metastasis and resistance to immunotherapy in TNBC
$371,074Besim Ogretmen · Medical University Of South Carolina · R01 · FY2025 · CA
T Cell Targeting for GVHD
$371,004Bruce R. Blazar · University Of Minnesota · R01 · FY2008 · HL
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
$370,994Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · CA
EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response
$370,980Marshall R Posner · Dana-Farber Cancer Inst · R21 · FY2009 · CA
Endogenous TLR1 signals prevent uncontrolled innate immunity in the colon
$370,969Randy William Depaolo · University Of Southern California · R01 · FY2015 · DK
Transgenesis and Xenotransplantation
$370,953Jorge A. Piedrahita · North Carolina State University Raleigh · R01 · FY2012 · HL
Identification of Melanoma Brain Metastasis Tumor Biomarkers
$370,950Dave S B Hoon · Saint John'S Cancer Institute · R01 · FY2014 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS
$370,946City Of Hope/Beckman Research Institute · U10 · FY2003 · CA
Regulation of human dendritic cell activation
$370,935Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune Response
$370,887Bali Pulendran · Stanford University · R37 · FY2017 · AI